
Novartis (NVS) Market Capitalization Overview
Market Cap: $292.79B as of Mar 13, 2026
$292.79B
$18.44B (5.92%)past month
As of Mar 13, 2026, Novartis (NVS) has a market capitalization of $292.79B. Over the past 30 days, its market cap has increased by 11.1%, while in the last 12 months, it has increased by 11.91%.
Market capitalization represents the total value of Novartis as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Novartis (NVS) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Novartis (NVS) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Novartis as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Novartis (NVS) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Novartis (NVS) helps investors assess the company's size and compare it with competitors for better investment decisions.
Novartis (NVS) Market Cap & Key Trends
See Novartis’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Novartis (NVS)
Order type
Buy in
Order amount
Est. shares
0 shares
Novartis (NVS) Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $244.74B | +4.13% |
| Nov 3, 2025 | $235.04B | -5.97% |
| Oct 1, 2025 | $249.95B | +4.01% |
| Sep 2, 2025 | $240.31B | +9.84% |
| Aug 1, 2025 | $218.80B | -6.34% |
| Jul 1, 2025 | $233.60B | +5.48% |
| Jun 2, 2025 | $221.45B | +4.82% |
| May 1, 2025 | $211.26B | +1.57% |
| Apr 1, 2025 | $207.99B | -4.80% |
| Mar 3, 2025 | $218.49B | +4.87% |
| Feb 3, 2025 | $208.34B | +9.62% |
| Jan 2, 2025 | $190.06B | -7.31% |
Novartis (NVS) End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $292.79B | +11.91% |
| 2025 | $261.62B | +37.42% |
| 2024 | $190.39B | -5.41% |
| 2023 | $201.28B | +6.32% |
| 2022 | $189.31B | +2.79% |
| 2021 | $184.18B | — |
FAQs About Novartis (NVS) Market Cap
As of Mar 13, 2026, the market capitalization of Novartis (NVS) is $292.79B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Novartis’s market capitalization has decreased by -5.92%, changing from $311.22B to $292.79B as of Mar 13, 2026.
In the last 3 months, Novartis’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Novartis’s market capitalization increased from $190.39B in January to $261.62B in December, reflecting a 37.42% change.
In the past five years, Novartis (NVS) has had a compound annual growth rate (CAGR) of 7.27% in market capitalization. This means its market cap has grown at an average rate of 7.27% per year.